Currently out of the existing stock ratings of Courtney Breen, 27 are a HOLD (55.1%), 22 are a BUY (44.9%).

Courtney Breen

Work Performance Price Targets & Ratings Chart

Analyst Courtney Breen, currently employed at BERNSTEIN, carries an average stock price target met ratio of 83.21% that have a potential upside of 16.91% achieved within 184 days.

Courtney Breen’s has documented 96 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AMGN, Amgen at 06-Aug-2026.

Wall Street Analyst Courtney Breen

Analyst best performing recommendations are on AMGN (AMGEN).
The best stock recommendation documented was for AMGN (AMGEN) at 1/20/2026. The price target of $335 was fulfilled within 1 day with a profit of $10.64 (3.28%) receiving and performance score of 32.8.

Average potential price target upside

ABBV AbbVie AMGN Amgen BMY Bristol-Myers Squibb Company GILD Gilead Sciences LLY Eli Lilly and Company MRK Merck mpany MRNA Moderna PFE Pfizer

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Sep-2026

$315

$50.66 (19.16%)

$265

21 days ago
(10-Sep-2026)

6/7 (85.71%)

$60 (23.53%)

115

Buy Since 12-Sep-2025

$303

$38.66 (14.63%)

$298

1 months 11 days ago
(20-Aug-2026)

2/12 (16.67%)

$41.17 (15.72%)

35

Buy Since 09-Dec-2021

$300

$35.66 (13.49%)

$295

1 months 14 days ago
(17-Aug-2026)

14/16 (87.5%)

$49.67 (19.84%)

506

Hold Since 13-Aug-2026

$300

$35.66 (13.49%)

1 months 18 days ago
(13-Aug-2026)

1/2 (50%)

$49.18 (19.61%)

115

Buy Since 23-Jan-2023

$260

$-4.34 (-1.64%)

$235

1 months 21 days ago
(10-Aug-2026)

9/9 (100%)

$12.03 (4.85%)

133

Show more analysts

Please expand the browser size to see the chart

Which stock is Courtney Breen most bullish on?

Potential upside of $200.22 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Courtney Breen most reserved on?

Potential downside of -$69.61 has been obtained for AMGN (AMGEN)

What Year was the first public recommendation made by Courtney Breen?

On 2024
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?